CPT 0415T: Repositioning Atrial or Ventricular Transvenous Electrode for CCM

CPT code 0415T covers repositioning of an atrial or ventricular transvenous electrode for a cardiac contractility modulation (CCM) system, a specialized device procedure used in select patients with heart failure. Nationally, this code captures a discrete device-related intervention that affects device function, perioperative workflow, and claims processing for electrophysiology services. Key payers in the review include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

This publication provides a concise overview of clinical context and billing considerations for 0415T, including typical sites of service (hospital-based electrophysiology labs and catheterization suites) and the procedural focus on lead repositioning for CCM systems. Readers will find benchmarks for payer coverage and payment patterns where available, summaries of common modifiers used in device and procedure billing, and clinical context explaining when lead repositioning is performed. Data not available in the input will be noted as such. The content is intended to support coding, billing, and administrative teams, as well as clinicians who coordinate device-related procedures, with clear, national-level information on the use and reporting of CPT code 0415T.

Billing Code Overview

CPT code 0415T describes the repositioning of an atrial or ventricular transvenous electrode for a cardiac contractility modulation (CCM) system. The procedure involves adjusting an electrode that transmits and receives electrical impulses; electrodes are typically attached to insulated wire leads that are placed transvenously into the heart.

Service type: Device-related electrophysiology procedure involving lead manipulation and repositioning.

Typical site of service: Hospital inpatient or outpatient cardiac electrophysiology lab or cardiac catheterization suite.

Clinical Context

A 68-year-old patient with symptomatic heart failure with reduced ejection fraction who previously received a cardiac contractility modulation (CCM) implant presents with recurrent chest discomfort and evidence of atrial or ventricular lead malfunction on device interrogation. The patient is evaluated in the electrophysiology clinic and scheduled for a same-day or short-stay procedure in the cardiac catheterization lab or electrophysiology suite. Under conscious sedation or general anesthesia, the electrophysiologist accesses the existing transvenous lead system, confirms lead instability or malposition by fluoroscopy and device testing, and repositions the atrial or ventricular transvenous electrode to restore appropriate sensing and delivery of CCM therapy. Intra-procedural testing verifies acceptable lead parameters and absence of complications. Post-procedure, the patient is monitored for vascular access issues, arrhythmia, or infection and discharged home or admitted for observation depending on clinical stability and institutional protocols. Typical site of service is an outpatient hospital-based electrophysiology lab or ambulatory surgery center; service type is an interventional cardiac electrophysiology procedure involving lead revision of a CCM system.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when work required is substantially greater than typical for lead repositioning due to complexity (document details and rationale).

Taxonomy Code	Specialty	Notes
207RH0000X	Cardiac Electrophysiology	Electrophysiologists perform CCM lead revisions and device programming.
207RC0000X	Cardiology	Interventional cardiologists with device expertise may perform or assist with lead repositioning.
208D00000X	General Surgery	Cardiothoracic surgeons may be involved when surgical exposure is required or complications occur.
163WL0500X	Nurse Practitioner	Advanced practice clinicians in electrophysiology clinics involved in pre- and post-procedural care.
207LH0000X	Internal Medicine	Hospitalist or cardiology inpatient teams manage medical optimization and post-procedure care.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`I50.2`	Systolic (congestive) heart failure	Heart failure with reduced ejection fraction is the primary indication for CCM therapy and for lead revision when device therapy is compromised.
`I50.9`	Heart failure, unspecified	Used when heart failure is documented but specific type is not specified; relevant when CCM system requires lead repositioning due to failure to deliver therapy.
`I42.0`	Dilated cardiomyopathy	Common underlying structural cause of reduced ejection fraction and indication for CCM device therapy; lead issues may arise with remodeling.
`I48.0`	Paroxysmal atrial fibrillation	Atrial arrhythmias can affect CCM sensing or therapy delivery and may necessitate atrial lead repositioning.
`T82.89XA`	Other mechanical complication of other cardiac device, implant and graft, initial encounter	Captures lead malfunction, displacement, or other mechanical complications requiring repositioning of CCM electrodes.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`33208`	Insertion or replacement of permanent pacemaker lead, transvenous, ventricular	May be performed if lead repositioning is unsuccessful and a new ventricular lead is required during the same episode of care.
`33207`	Insertion or replacement of permanent pacemaker lead, transvenous, atrial	May be performed when atrial lead revision cannot be achieved by repositioning and replacement is necessary.
`33233`	Removal of pacemaker lead(s), transvenous extraction by traction and/or simple manual technique	May precede or accompany lead repositioning if extraction of a malfunctioning lead is required.
`33249`	Insertion of temporary transvenous pacing electrode, without permanent pacemaker	May be used temporarily intra-procedurally if hemodynamic support or pacing is required during lead manipulation.
`93660`	Comprehensive electrophysiologic evaluation including insertion and repositioning of electrode catheters	May be performed during the same session for diagnostic mapping or to assess arrhythmia substrate while addressing lead position.

OpenPayer

Summary & Overview